Cormorant Asset Management, LP - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 201 filers reported holding REATA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.6%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$10,061,000
-57.7%
100,000
-40.5%
0.41%
-49.4%
Q2 2021$23,798,000
-40.3%
168,150
-58.0%
0.81%
-9.0%
Q1 2021$39,880,000
-35.5%
400,000
-20.0%
0.89%
-39.6%
Q4 2020$61,810,000
+41.0%
500,000
+11.1%
1.47%
-12.8%
Q3 2020$43,839,000
-29.8%
450,000
+12.5%
1.69%
-29.2%
Q2 2020$62,408,000
-41.4%
400,000
-45.7%
2.38%
-51.9%
Q1 2020$106,408,000
-51.2%
737,206
-30.9%
4.94%
-43.2%
Q4 2019$218,005,000
+231.2%
1,066,400
+30.1%
8.70%
+117.1%
Q3 2019$65,819,000
-13.5%
819,769
+1.7%
4.01%
-8.3%
Q2 2019$76,060,000
+44.7%
806,150
+31.1%
4.37%
+23.0%
Q1 2019$52,564,000
+39.0%
615,000
-8.8%
3.55%
+15.7%
Q4 2018$37,825,000
-29.9%
674,251
+2.2%
3.07%
-12.4%
Q3 2018$53,962,000
+242.9%
660,000
+46.7%
3.51%
+201.0%
Q2 2018$15,737,000
+70.5%
450,0000.0%1.16%
+69.3%
Q1 2018$9,230,000
+63.0%
450,000
+125.0%
0.69%
+16.0%
Q4 2017$5,664,000
-53.1%
200,000
-48.5%
0.59%
-72.2%
Q3 2017$12,085,000388,5742.13%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders